New Jersey Pharma Plant Finds an Angel With “Halo,” an Industrial Info News Alert

Researched by Industrial Info Resources (Sugar Land, Texas) — As part of its consolidation strategy, Abbott Laboratories (NYSE:ABT) (Abbott Park, Illinois) will divest its 134-employee manufacturing plant in Whippany, New Jersey, by the end of the year. However, a small biotech start-up firm has agreed to purchase the facility and take ownership by December 1. This is rare and welcome news for the citizens of Whippany and Morris County who, within the last year, were notified that the region will lose three of its biggest taxpayers.

For details, view the entire article by subscribing to Industrial Info’s Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=140294, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR) is a marketing information service specializing in industrial process, energy and financial related markets with products and services ranging from industry news, analytics, forecasting, plant and project databases, as well as multimedia services. For more information send inquiries to pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com.

Related News Articles

With $6.1 Billion in Play, Massachusetts Dominates Pharma-Biotech’s Capital Investment in New England

St. Jude Medical Resurrects Former Guidant Plant to Produce Pacemakers in Puerto Rico

BE&K Building Group Completes $22 Million Biomanufacturing Plant in Baltimore for CEL-SCI

 Contact: Joe Govreau 713-783-5147  

SOURCE: Industrial Info Resources